RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX (DYG); Cancer Preventive Medicine, Hokkaido University Graduate School of Medicine, Hokkaido, Japan (MA). dgraham@bcm.edu.
David Y
DY
Graham
Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX (DYG); Cancer Preventive Medicine, Hokkaido University Graduate School of Medicine, Hokkaido, Japan (MA).
Masahiro
M
Asaka
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D011230:Precancerous Conditions / Q000188:drug therapy*; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*
D000900:Anti-Bacterial Agents